Hennion & Walsh Asset Management’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-4,590
Closed -$221K 1006
2026
Q1
$221K Buy
4,590
+440
+11% +$20.5K 0.01% 883
2025
Q4
$201K Sell
4,150
-728
-15% -$36.1K 0.01% 909
2025
Q3
$230K Sell
4,878
-1,937
-28% -$93.5K 0.01% 897
2025
Q2
$329K Buy
6,815
+1,327
+24% +$67.8K 0.01% 786
2025
Q1
$304K Sell
5,488
-1,272
-19% -$68.9K 0.01% 758
2024
Q4
$326K Sell
6,760
-335
-5% -$17K 0.01% 737
2024
Q3
$409K Sell
7,095
-3,407
-32% -$184K 0.02% 666
2024
Q2
$510K Sell
10,502
-2,699
-20% -$130K 0.03% 586
2024
Q1
$642K Buy
13,201
+106
+0.8% +$5.18K 0.03% 518
2023
Q4
$651K Buy
13,095
+2,767
+27% +$135K 0.04% 505
2023
Q3
$554K Buy
10,328
+1,466
+17% +$78.2K 0.04% 492
2023
Q2
$478K Buy
8,862
+522
+6% +$28.1K 0.03% 518
2023
Q1
$454K Buy
8,340
+995
+14% +$48.4K 0.03% 523
2022
Q4
$356K Sell
7,345
-1,171
-14% -$51.4K 0.02% 580
2022
Q3
$324K Buy
+8,516
New +$379K 0.02% 586

Other funds holding SNY

Hennion & Walsh Asset Management's SNY Position: Q2 2026 in Review

Hennion & Walsh Asset Management sold out of Sanofi (SNY) in Q2 2026, closing a stake of 4,590 shares — an estimated $221K sold.

Hennion & Walsh Asset Management first reported a position in SNY in Q3 2022 and held it in 15 quarters. The position peaked at $651K in Q4 2023. 108 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Hennion & Walsh Asset Management reported no remaining Sanofi position as of Q2 2026 after selling out during the quarter.
  • Hennion & Walsh Asset Management sold 4,590 Sanofi shares in Q2 2026, an estimated $221K.
  • Hennion & Walsh Asset Management first reported a position in Sanofi in Q3 2022 and held it in 15 quarters.
  • Hennion & Walsh Asset Management's Sanofi position peaked at $651K in Q4 2023.
  • 108 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Hennion & Walsh Asset Management's 13F filing for Q2 2026, filed 8 Jul 2026.